{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:59:12Z","timestamp":1790881152662,"version":"4.1.0"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"30","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7,24]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Skin cancer has emerged as a major global health challenge, with persistent variations in the burden across countries and regions. The objective of this study was to evaluate the global, regional, and national burden of malignant melanoma (MM), squamous cell carcinoma, and basal cell carcinoma from 1990 to 2021, and to analyze their temporal trends and associations with the Socio-demographic Index. We selected data on cancer incidence, mortality, and disability-adjusted life years (DALYs) from 204 countries and regions between 1990 and 2021, using the Global Burden of Disease 2021 study. Temporal trends were quantified by calculating the incidence, mortality, and DALY rates as well as their percentage changes, while also analyzing the association between DALYs and Socio-demographic Index. Globally in 2021, 2.3 million cases of illness, 61.5 thousand deaths, and 1678.8 thousand DALYs were attributed to MM; squamous cell carcinoma caused 2.8 million prevalent cases, 56.9 thousand deaths, and 1210.9 thousand DALYs; and basal cell carcinoma accounted for 2.2 million epidemic cases and 2 thousand DALYs. Epidemic cases, deaths, DALYs counts, and age-standardized point rates are rising, but MM-induced deaths and DALYs rates have declined over the past 3 decades. The burden of skin cancer is higher in Australasia and High-income North America than in other regions. Under the Global Burden of Disease regional classifications, Australasia comprises Australia, New Zealand, and surrounding territories, while High-income North America encompasses the United States and Canada. At the national level, the burden is higher in Australia, New Zealand, and the United States; the burden is generally higher in men than in women, and is higher in older adults than in young people. Our study indicates that skin cancer remains an important public health issue worldwide. High-income regions such as Australasia and North America will continue to bear the greatest burden. Simultaneously, the burden on East Asia, Latin America, and Africa is rapidly increasing. This study also showed that the disease burden was greater in men and older adults. Therefore, countries and regions should attach great importance to the prevention and treatment of skin cancers, and develop and improve preventive measures.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000049757","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T19:00:49Z","timestamp":1784919649000},"page":"e49757","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Global burden of skin cancers and trends from 1990 to 2021: An observational study based on secondary analysis of GBD 2021"],"prefix":"10.1097","volume":"105","author":[{"given":"Ruosu","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Dermatology, The Second Hospital of Hebei Medical University, Clinical Medical Research Center of Dermatology and Venereal in Hebei Province, Construction Unit of the Sub-center of the National Center for Clinical Medical Research on Skin and Immunological Diseases, Shijiazhuang, Hebei, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yike","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The Second Hospital of Hebei Medical University, Clinical Medical Research Center of Dermatology and Venereal in Hebei Province, Construction Unit of the Sub-center of the National Center for Clinical Medical Research on Skin and Immunological Diseases, Shijiazhuang, Hebei, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0805-1518","authenticated-orcid":false,"given":"Yanling","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The Second Hospital of Hebei Medical University, Clinical Medical Research Center of Dermatology and Venereal in Hebei Province, Construction Unit of the Sub-center of the National Center for Clinical Medical Research on Skin and Immunological Diseases, Shijiazhuang, Hebei, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261001","doi-asserted-by":"crossref","first-page":"4905","DOI":"10.1002\/cam4.4046","article-title":"Global, regional and national incidence, mortality and disability-adjusted life-years of skin cancers and trend analysis from 1990 to 2019: an analysis of the Global Burden of Disease Study 2019.","volume":"10","author":"Zhang","year":"2021","journal-title":"Cancer Med"},{"key":"R2-20261001","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1365-2133.2012.10830.x","article-title":"A systematic review of worldwide incidence of nonmelanoma skin cancer.","volume":"166","author":"Lomas","year":"2012","journal-title":"Br J Dermatol"},{"key":"R3-20261001","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R4-20261001","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.pop.2015.07.006","article-title":"Skin cancer.","volume":"42","author":"Linares","year":"2015","journal-title":"Prim Care"},{"key":"R5-20261001","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1001\/jamaoncol.2019.2996","article-title":"Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the Global Burden of Disease Study.","volume":"5","author":"Fitzmaurice","year":"2019","journal-title":"JAMA Oncol"},{"key":"R6-20261001","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.soncn.2013.06.002","article-title":"Skin cancer: an overview of epidemiology and risk factors.","volume":"29","author":"Gordon","year":"2013","journal-title":"Semin Oncol Nurs"},{"key":"R7-20261001","first-page":"205","article-title":"Economic burden of skin cancer treatment in the USA: an analysis of the Medical Expenditure Panel Survey Data, 2012-2018.","volume":"34","author":"Kao","year":"2023","journal-title":"Cancer Causes Control"},{"key":"R8-20261001","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.cps.2021.05.001","article-title":"Melanoma risk factors and prevention.","volume":"48","author":"Dzwierzynski","year":"2021","journal-title":"Clin Plast Surg"},{"key":"R9-20261001","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1186\/s12967-024-05719-1","article-title":"A genetically informed study reveals modifiable pathways in skin cancer.","volume":"22","author":"Qian","year":"2024","journal-title":"J Transl Med"},{"issue":"5 Suppl 1","key":"R10-20261001","first-page":"S133","article-title":"The health burden and economic costs of cutaneous melanoma mortality by race\/ethnicity-United States, 2000 to 2006.","volume":"65","author":"Ekwueme","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"R11-20261001","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.det.2019.05.009","article-title":"Basal cell carcinoma, squamous cell carcinoma, and cutaneous melanoma in skin of color patients.","volume":"37","author":"Hogue","year":"2019","journal-title":"Dermatol Clin"},{"key":"R12-20261001","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s40164-025-00634-7","article-title":"Disparities in the incidence, mortality and disability-adjusted life years of 33 early-onset cancer groups globally, 2012-2021: a systematic analysis.","volume":"14","author":"Yan","year":"2025","journal-title":"Exp Hematol Oncol"},{"key":"R13-20261001","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s13045-024-01640-8","article-title":"Global burden of cancer and associated risk factors in 204 countries and territories, 1980-2021: a systematic analysis for the GBD 2021.","volume":"17","author":"Wu","year":"2024","journal-title":"J Hematol Oncol"},{"key":"R14-20261001","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jdin.2020.10.013","article-title":"The global burden of skin cancer: a longitudinal analysis from the Global Burden of Disease Study, 1990-2017.","volume":"2","author":"Urban","year":"2021","journal-title":"JAAD Int"},{"key":"R15-20261001","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"R16-20261001","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/bjd\/ljac064","article-title":"Trends in keratinocyte skin cancer incidence, mortality and burden of disease in 33 countries between 1990 and 2017.","volume":"188","author":"Yang","year":"2023","journal-title":"Br J Dermatol"},{"key":"R17-20261001","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jaad.2024.09.035","article-title":"Global trends in melanoma burden: a comprehensive analysis from the Global Burden of Disease Study, 1990-2021.","volume":"92","author":"Sun","year":"2025","journal-title":"J Am Acad Dermatol"},{"key":"R18-20261001","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.soncn.2016.05.005","article-title":"Ultraviolet radiation exposure and its impact on skin cancer risk.","volume":"32","author":"Watson","year":"2016","journal-title":"Semin Oncol Nurs"},{"key":"R19-20261001","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.hoc.2018.09.004","article-title":"Basal cell carcinoma review.","volume":"33","author":"Kim","year":"2019","journal-title":"Hematol Oncol Clin North Am"},{"key":"R20-20261001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.hoc.2018.08.001","article-title":"Cutaneous squamous cell carcinoma.","volume":"33","author":"Waldman","year":"2019","journal-title":"Hematol Oncol Clin North Am"},{"key":"R21-20261001","doi-asserted-by":"crossref","first-page":"122011","DOI":"10.1007\/s11356-023-30535-3","article-title":"Childhood sunburn and risk of melanoma and non-melanoma skin cancer: a Mendelian randomization study.","volume":"30","author":"Li","year":"2023","journal-title":"Environ Sci Pollut Res Int"},{"key":"R22-20261001","doi-asserted-by":"crossref","first-page":"108226","DOI":"10.1016\/j.envint.2023.108226","article-title":"Global, regional and national burdens of non-melanoma skin cancer attributable to occupational exposure to solar ultraviolet radiation for 183 countries, 2000-2019: a systematic analysis from the WHO\/ILO Joint Estimates of the Work-related Burden of Disease and Injury.","volume":"181","author":"Pega","year":"2023","journal-title":"Environ Int"},{"key":"R23-20261001","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1001\/jamadermatol.2020.4616","article-title":"UV exposure and the risk of cutaneous melanoma in skin of color: a systematic review.","volume":"157","author":"Lopes","year":"2021","journal-title":"JAMA Dermatol"},{"key":"R24-20261001","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1158\/1055-9965.EPI-13-1317","article-title":"The global burden of disease for skin, lung, and bladder cancer caused by arsenic in food.","volume":"23","author":"Oberoi","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R25-20261001","first-page":"109","article-title":"Eye color and the risk of skin cancer.","volume":"33","author":"Li","year":"2022","journal-title":"Cancer Causes Control"},{"key":"R26-20261001","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.det.2018.07.009","article-title":"Skin cancer and immunosuppression.","volume":"37","author":"Collins","year":"2019","journal-title":"Dermatol Clin"},{"key":"R27-20261001","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00403-024-03046-5","article-title":"The burden of skin diseases in China: Global Burden of Disease Study 2019.","volume":"316","author":"Kong","year":"2024","journal-title":"Arch Dermatol Res"},{"key":"R28-20261001","doi-asserted-by":"crossref","first-page":"1486617","DOI":"10.3389\/fpubh.2024.1486617","article-title":"Burden of melanoma in China and its provinces from 1990 to 2021: an analysis for the Global Burden of Disease Study 2021.","volume":"12","author":"Yu","year":"2024","journal-title":"Front Public Health"},{"key":"R29-20261001","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jdin.2020.10.006","article-title":"Burden of skin disease and associated socioeconomic status in Asia: a cross-sectional analysis from the Global Burden of Disease Study 1990-2017.","volume":"2","author":"Urban","year":"2021","journal-title":"JAAD Int"},{"key":"R30-20261001","doi-asserted-by":"crossref","first-page":"04144","DOI":"10.7189\/jogh.14.04144","article-title":"Impact of population ageing on cancer-related disability-adjusted life years: a global decomposition analysis.","volume":"14","author":"Zhu","year":"2024","journal-title":"J Glob Health"},{"key":"R31-20261001","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1016\/S2468-2667(19)30019-2","article-title":"Measuring population ageing: an analysis of the Global Burden of Disease Study 2017.","volume":"4","author":"Chang","year":"2019","journal-title":"Lancet Public Health"},{"key":"R32-20261001","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1007\/s00103-018-2833-9","article-title":"Cancer screening and early diagnosis in low and middle income countries: current situation and future perspectives.","volume":"61","author":"Mandal","year":"2018","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"R33-20261001","first-page":"1","article-title":"Cancer control in low- and middle-income countries: is it time to consider screening?","volume":"5","author":"Shah","year":"2019","journal-title":"J Glob Oncol"},{"key":"R34-20261001","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1111\/jdv.20524","article-title":"Trends in cutaneous melanoma mortality and incidence in European Union 15+ countries between 1990 and 2019.","volume":"39","author":"Wang","year":"2025","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R35-20261001","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jaad.2021.03.109","article-title":"United States burden of melanoma and non-melanoma skin cancer from 1990 to 2019.","volume":"85","author":"Aggarwal","year":"2021","journal-title":"J Am Acad Dermatol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000049757","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:01:00Z","timestamp":1790877660000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000049757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":35,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000049757","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]},"assertion":[{"value":"2026-02-17","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-26","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}